Comparative risks of dementia and Parkinson’s disease with GLP-1 RAs versus other oral glucose-lowering medications in obese patients with type 2 diabetes: a large real-world cohort study
Study Overview This study investigates the comparative risks associated with dementia and Parkinson’s disease in obese individuals suffering from type […]
